Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Contact Dermatitis: full-pipeline trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Contact Dermatitis: 4 US clinical trials tracked, none currently recruiting.
Contact Dermatitis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Hapten Sciences, running 1 of these trials.
Enrollment posture brief
Registry condition contact-dermatitis
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Contact Dermatitis has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Contact Dermatitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Contact Dermatitis is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Allerderm
NCT00640614
DermAI to Evaluate Human Factor of Testing
Mayo Clinic
NCT06387472
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
Hapten Sciences
NCT02700373
Molecular and Cellular Characterization of Spongiotic Dermatitis
University of California, Davis
NCT00371163
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Contact Dermatitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Contact Dermatitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Contact Dermatitis page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Contact Dermatitis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Hapten Sciences sponsors the most Contact Dermatitis trials on record, review their full trial history before evaluating a specific study. See Hapten Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Contact Dermatitis condition card totals 4 registered trials; most-linked intervention PDC-APB; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.